First Time Loading...
N

Neuca SA
WSE:NEU

Watchlist Manager
Neuca SA
WSE:NEU
Watchlist
Price: 945 PLN
Updated: May 15, 2024

Intrinsic Value

NEUCA SA engages in the wholesale of pharmaceutical products. [ Read More ]

The intrinsic value of one NEU stock under the Base Case scenario is 1 503.98 PLN. Compared to the current market price of 945 PLN, Neuca SA is Undervalued by 37%.

Key Points:
NEU Intrinsic Value
Base Case
1 503.98 PLN
Undervaluation 37%
Intrinsic Value
Price
N
Worst Case
Base Case
Best Case

Valuation Backtest
Neuca SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling NEU stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Neuca SA

Provide an overview of the primary business activities
of Neuca SA.

What unique competitive advantages
does Neuca SA hold over its rivals?

What risks and challenges
does Neuca SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Neuca SA.

Provide P/S
for Neuca SA.

Provide P/E
for Neuca SA.

Provide P/OCF
for Neuca SA.

Provide P/FCFE
for Neuca SA.

Provide P/B
for Neuca SA.

Provide EV/S
for Neuca SA.

Provide EV/GP
for Neuca SA.

Provide EV/EBITDA
for Neuca SA.

Provide EV/EBIT
for Neuca SA.

Provide EV/OCF
for Neuca SA.

Provide EV/FCFF
for Neuca SA.

Provide EV/IC
for Neuca SA.

Show me price targets
for Neuca SA made by professional analysts.

What are the Revenue projections
for Neuca SA?

How accurate were the past Revenue estimates
for Neuca SA?

What are the Net Income projections
for Neuca SA?

How accurate were the past Net Income estimates
for Neuca SA?

What are the EPS projections
for Neuca SA?

How accurate were the past EPS estimates
for Neuca SA?

What are the EBIT projections
for Neuca SA?

How accurate were the past EBIT estimates
for Neuca SA?

Compare the revenue forecasts
for Neuca SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Neuca SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Neuca SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Neuca SA compared to its peers.

Compare the P/E ratios
of Neuca SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Neuca SA with its peers.

Analyze the financial leverage
of Neuca SA compared to its main competitors.

Show all profitability ratios
for Neuca SA.

Provide ROE
for Neuca SA.

Provide ROA
for Neuca SA.

Provide ROIC
for Neuca SA.

Provide ROCE
for Neuca SA.

Provide Gross Margin
for Neuca SA.

Provide Operating Margin
for Neuca SA.

Provide Net Margin
for Neuca SA.

Provide FCF Margin
for Neuca SA.

Show all solvency ratios
for Neuca SA.

Provide D/E Ratio
for Neuca SA.

Provide D/A Ratio
for Neuca SA.

Provide Interest Coverage Ratio
for Neuca SA.

Provide Altman Z-Score Ratio
for Neuca SA.

Provide Quick Ratio
for Neuca SA.

Provide Current Ratio
for Neuca SA.

Provide Cash Ratio
for Neuca SA.

What is the historical Revenue growth
over the last 5 years for Neuca SA?

What is the historical Net Income growth
over the last 5 years for Neuca SA?

What is the current Free Cash Flow
of Neuca SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Neuca SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Neuca SA

Current Assets 3.3B
Cash & Short-Term Investments 119.5m
Receivables 1.7B
Other Current Assets 1.5B
Non-Current Assets 1.9B
Long-Term Investments 84.8m
PP&E 658.7m
Intangibles 1.1B
Other Non-Current Assets 17.4m
Current Liabilities 3.8B
Accounts Payable 3.3B
Accrued Liabilities 13.1m
Short-Term Debt 159.8m
Other Current Liabilities 334.2m
Non-Current Liabilities 418.9m
Long-Term Debt 151m
Other Non-Current Liabilities 268m
Efficiency

Earnings Waterfall
Neuca SA

Revenue
11.8B PLN
Cost of Revenue
-10.5B PLN
Gross Profit
1.3B PLN
Operating Expenses
-1B PLN
Operating Income
265.8m PLN
Other Expenses
-119.5m PLN
Net Income
146.3m PLN

Free Cash Flow Analysis
Neuca SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

NEU Profitability Score
Profitability Due Diligence

Neuca SA's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive 3-Year Average ROE
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive ROE
50/100
Profitability
Score

Neuca SA's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

NEU Solvency Score
Solvency Due Diligence

Neuca SA's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Low D/E
High Altman Z-Score
Long-Term Solvency
Short-Term Solvency
47/100
Solvency
Score

Neuca SA's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NEU Price Targets Summary
Neuca SA

Wall Street analysts forecast NEU stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NEU is 919.28 PLN with a low forecast of 757.5 PLN and a high forecast of 1 119.3 PLN.

Lowest
Price Target
757.5 PLN
20% Downside
Average
Price Target
919.28 PLN
3% Downside
Highest
Price Target
1 119.3 PLN
18% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

NEU Price
Neuca SA

1M 1M
+6%
6M 6M
+22%
1Y 1Y
+34%
3Y 3Y
+20%
5Y 5Y
+246%
10Y 10Y
+385%
Annual Price Range
945
52w Low
659
52w High
945
Price Metrics
Average Annual Return 29.6%
Standard Deviation of Annual Returns 40.92%
Max Drawdown -3%
Shares Statistics
Market Capitalization 4.2B PLN
Shares Outstanding 4 447 185
Percentage of Shares Shorted
N/A

NEU Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Neuca SA

Country

Poland

Industry

Health Care

Market Cap

4.2B PLN

Dividend Yield

1.4%

Description

NEUCA SA engages in the wholesale of pharmaceutical products. The company is headquartered in Torun, Woj. Kujawsko - Pomorskie and currently employs 3,852 full-time employees. The company went IPO on 2004-09-30. The firm is mainly involved in the distribution of drugs to pharmacies. The company also operates in other sectors of the health market, such as production of drugs, supplements and cosmetics under its own brand, clinical trials, telemedicine, Information Technology (IT) solutions and e-commerce in the health care industry.

Contact

WOJ. KUJAWSKO - POMORSKIE
Torun
ul. Forteczna 35-37
+48566694000.0
https://www.neuca.pl/

IPO

2004-09-30

Employees

3 852

Officers

President of the Management Board & General Director
Mr. Piotr Sucharski
VP of Management Board & CFO
Mr. Grzegorz Dzik
Vice President of Management Board for Operations
Mr. Krzysztof Miszewski
Vice President of the Management Board & Director of the Sales Division
Mr. Daniel Wojtkiewicz
Vice President of the Management Board for the Patient Area
Ms. Julita Czyzewska
Vice President of the Management Board the Board of Directors for the IT Division
Mr. Roman Dudzik

See Also

Discover More
What is the Intrinsic Value of one NEU stock?

The intrinsic value of one NEU stock under the Base Case scenario is 1 503.98 PLN.

Is NEU stock undervalued or overvalued?

Compared to the current market price of 945 PLN, Neuca SA is Undervalued by 37%.